A novel cytotoxic T-cell epitope presented by HLA-A24 molecule in hepatitis C virus infection

Journal of Hepatology

Volumn 34, Issue 6, 2001, Pages 930-935

  Kurokohchi, Kazutaka ^a   Arima, Keiji ^a   Nishioka, Mikio ^a  

^a KAGAWA UNIVERSITY   (Japan)

Author keywords

Cytotoxic T lymphocytes (CTL); Hepatitis C virus; HLA A24; T cell epitope

Indexed keywords

ANTIBODY; CD8 ANTIGEN; EPITOPE; HLA A ANTIGEN; SYNTHETIC PEPTIDE;

ANTIGEN PRESENTATION; ANTIGEN RECOGNITION; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; CYTOTOXIC T LYMPHOCYTE; HEPATITIS C; HEPATITIS C VIRUS; HUMAN; HUMAN CELL; IMMUNOSTIMULATION; MONONUCLEAR CELL; PRIORITY JOURNAL;

AMINO ACID MOTIFS; AMINO ACID SEQUENCE; ANTIBODIES, BLOCKING; ANTIGEN PRESENTATION; BINDING SITES; CASE-CONTROL STUDIES; CELL LINE; EPITOPE MAPPING; HEPACIVIRUS; HEPATITIS B ANTIGENS; HEPATITIS C, CHRONIC; HLA-A ANTIGENS; HUMANS; IMMUNODOMINANT EPITOPES; T-LYMPHOCYTES, CYTOTOXIC; TRANSFECTION;

EID: 0034954530     PISSN: 01688278     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0168-8278(01)00041-1     Document Type: Article

References (29)

1. Isolation of a cDNA clone derived from a blood-borne non-A, non-B viral hepatitis genome
2. An assay for circulating antibodies to a major etiologic virus of human non-A, non-B hepatitis
3. Hepatitis C virus infection is associated with the development of hepatocellular carcinoma
4. Immunopathology of hepatitis C
5. Use of recombinant protein to identify a motif-negative human cytotoxic T-cell epitope presented by HLA-A2 in the hepatitis C virus NS3 region
6. Characteristics of the intrahepatic cytotoxic T lymphocyte response in chronic hepatitis C virus infection
7. Examination of serological HLA antigen
8. Antigen and gene frequencies of ethnic groups: HLA in Asia-Oceania
9. MHC ligands and peptide motifs: First listing
10. CARE-LASWS (calcein-release-assay), an improved fluorescence-based test system to measure cytotoxic T lymphocyte activity
11. Production of nonstructural proteins of hepatitis C virus requires a putative viral protease encoded by NS3
12. Characterization of the hepatitis C virus-encoded serine proteinase: Determination of proteinase-dependent polyprotein cleavage sites
13. Expression and identification of hepatitis C virus polyprotein cleavage products
14. Structure and organization of the hepatitis C virus genome isolated from human carriers
15. Molecular structure of the Japanese hepatitis C viral genome
16. TH1 and TH2 cells: Different patterns of lymphokine secretion lead to different functional properties
17. MHC-restricted cytotoxic T cells: Studies on the biological role of polymorphic major transplantation antigens determining T-cell restriction-specificity, function and responsiveness
18. Intrahepatic hepatitis C virus-specific cytotoxic T lymphocyte activity and response to interferon alpha therapy in chronic hepatitis C
19. Cytotoxic T lymphocyte response and viral load in hepatitis C virus infection
20. Differential cytotoxic T-lymphocyte responsiveness to the hepatitis B and C viruses in chronically infected patients
21. The class I-restricted cytotoxic T lymphocyte response to predetermined epitopes in the hepatitis B and C viruses
22. + T-cell epitope within nonstructural protein 3 in acute hepatitis C virus infection
23. Characterization of the hepatitis C virus-encoded serine proteinase: Determination of proteinase-dependent polyprotein cleavage products
24. Two distinct proteinase activities required for the processing of a putative nonstructural precursor protein of hepatitis C virus
25. Molecular biology of the hepatitis C viruses: Implications for diagnosis, development and control of viral disease
26. + T lymphocytes by murine monoclonal CD8 antibodies and restored specific T cell proliferation in vivo in a patient with chronic hepatitis C
27. Approaches to improve engineered vaccines for human immunodeficiency virus and other viruses that cause chronic infections
28. The hepatitis B virus-specific CTL responses induced in humans by lipopeptide vaccination are comparable to those elicited by acute viral infection
29. The multi-epitope polypeptide approach in HIV-1 vaccine development